Catalyst Wire Dossier Catalyst Wire Dossier

Modified House Dust Mite Allergen Extracts for Specific Immunotherapy

· Roxall Medizin
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Modified House Dust Mite Allergen Extracts for Specific Immunotherapy, covering 2015-11-03 to 2015-11-03. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Efficacy and Safety of Specific Immunotherapy With Modified Allergen Extracts of House Dust Mites [Phase 3]

See pricing